From Wikipedia, the free encyclopedia
Chemical compound
1P-AL-LAD
|
|
(6aR,9R)-N,N-diethyl-4-propanoyl-7-prop-2-enyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
|
PubChem
CID | |
---|
|
Formula | C25H31N3O2 |
---|
Molar mass | 405.542 g·mol−1 |
---|
3D model (
JSmol) | |
---|
CCC(=O)N1C=C2C[C@@H]3C(=C[C@H](CN3CC=C)C(=O)N(CC)CC)C4=C2C1=CC=C4
|
InChI=1S/C25H31N3O2/c1-5-12-27-15-18(25(30)26(7-3)8-4)13-20-19-10-9-11-21-24(19)17(14-22(20)27)16-28(21)23(29)6-2/h5,9-11,13,16,18,22H,1,6-8,12,14-15H2,2-4H3/t18-,22-/m1/s1 Key:GAGOTJNMWJYWMB-XMSQKQJNSA-N
|
1P-AL-LAD is a derivative of
lysergic acid diethylamide (LSD) which has
psychedelic effects and has been sold as a
designer drug. It is believed to act as a
prodrug for
AL-LAD and produces a
head-twitch response in animal studies.
[1]
See also
References
|
---|
Psychedelics (
5-HT2A agonists) |
Benzofurans | |
---|
Lyserg‐ amides | |
---|
Phenethyl‐ amines |
2C-x |
25x-NBx | 25x-
NB | |
---|
25x-
NB3OMe | |
---|
25x-
NB4OMe | |
---|
25x-
NBF | |
---|
25x-
NBMD | |
---|
25x-
NBOH | |
---|
25x-
NBOMe | |
---|
Atypical structures | |
---|
|
---|
25x-NMx | |
---|
N-(2C)-fentanyl | |
---|
|
---|
3C-x | |
---|
4C-x | |
---|
DOx | |
---|
HOT-x | |
---|
MDxx | |
---|
Mescaline (subst.) | |
---|
TMAs |
- TMA
- TMA-2
- TMA-3
- TMA-4
- TMA-5
- TMA-6
|
---|
Others | |
---|
|
---|
Piperazines | |
---|
Tryptamines |
alpha-alkyltryptamines | |
---|
x-
DALT | |
---|
x-
DET | |
---|
x-
DiPT | |
---|
x-
DMT |
-
4,5-DHP-DMT
-
2,N,N-TMT
-
4-AcO-DMT
-
4-HO-5-MeO-DMT
-
4,N,N-TMT
-
4-Propionyloxy-DMT
-
5,6-diBr-DMT
-
5-AcO-DMT
-
5-Bromo-DMT
-
5-MeO-2,N,N-TMT
-
5-MeO-4,N,N-TMT
-
5-MeO-α,N,N-TMT
-
5-MeO-DMT
-
5-N,N-TMT
-
7,N,N-TMT
-
α,N,N-TMT
-
(Bufotenin) 5-HO-DMT
-
DMT
-
Norbaeocystin
-
(Psilocin) 4-HO-DMT
-
(Psilocybin) 4-PO-DMT
|
---|
x-
DPT | |
---|
Ibogaine-related | |
---|
x-
MET | |
---|
x-
MiPT | |
---|
Others | |
---|
|
---|
Others | |
---|
|
---|
Dissociatives (
NMDAR
antagonists) | |
---|
Deliriants (
mAChR
antagonists) | |
---|
Others | |
---|